Original Research

Published on 18 Jul 2023

Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures

in Pharmacology of Anti-Cancer Drugs

Tomasz Kloskowski
Zuzanna Fekner
Kamil Szeliski
Michelle Paradowska
Daria Balcerczyk
Marta Rasmus
Paweł Dąbrowski
Łukasz Kaźmierski
Tomasz Drewa
Marta Pokrywczyńska

Frontiers in Oncology

doi 10.3389/fonc.2023.1222411

2,415 views
3 citations

Review

Published on 14 Jul 2023

A literature review on the impact of disasters on healthcare systems, the role of nursing in disaster management, and strategies for cancer care delivery in disaster-affected populations

in Pharmacology of Anti-Cancer Drugs

Wen Wang
Hui Li
Miao Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1178092

5,991 views
5 citations

Original Research

Published on 11 Jul 2023

PIWIL1 interacting RNA piR-017724 inhibits proliferation, invasion, and migration, and inhibits the development of HCC by silencing PLIN3

in Pharmacology of Anti-Cancer Drugs

Yi-Jing Wu
Jie Wang
Peng Zhang
Liu-Xia Yuan
Lin-Ling Ju
Hui-Xuan Wang
Lin Chen
Ya-Li Cao
Wei-Hua Cai
Yi Ni

Frontiers in Oncology

doi 10.3389/fonc.2023.1203821

1,897 views
6 citations

Review

Published on 10 Jul 2023

Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens

in Pharmacology of Anti-Cancer Drugs

Nityanand Srivastava
Salman Sadullah Usmani
Rajasekaran Subbarayan
Rashmi Saini
Pranav Kumar Pandey

Frontiers in Oncology

doi 10.3389/fonc.2023.1199105

7,846 views
12 citations

Review

Published on 06 Jul 2023

Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects

in Pharmacology of Anti-Cancer Drugs

Manasa Manjunath Hegde
Puja Sandbhor
Aishwarya J.
Vikram Gota
Jayant S. Goda

Frontiers in Oncology

doi 10.3389/fonc.2023.1168454

2,599 views
2 citations

Review

Published on 04 Jul 2023

Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies

in Pharmacology of Anti-Cancer Drugs

Ram Kumar Sahu
Sakina Ruhi
Ashok Kumar Jeppu
Husni Ahmed Al-Goshae
Ayesha Syed
Sanjay Nagdev
Retno Widyowati
Wiwied Ekasari
Jiyauddin Khan
Bedanta Bhattacharjee

Frontiers in Oncology

doi 10.3389/fonc.2023.1204722

8,010 views
10 citations

Case Report

Published on 03 Jul 2023

Intravenous immunoglobulin is safe and effective in controlling pre-existing paraneoplastic neuromuscular diseases in cancer patients treated with immune checkpoint inhibitors: two case reports and literature review

in Pharmacology of Anti-Cancer Drugs

Ge Xiong
Richard Benjamin Young
Helen Chow
Emanual Maverakis
Ricardo A. Maselli
David Paul Richman
Tianhong Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1199195

3,110 views
2 citations

Case Report

Published on 30 Jun 2023

Case Report: Advanced pulmonary sarcomatoid carcinoma with adrenal gland metastasis after sintilimab combined with anlotinib treatment

in Pharmacology of Anti-Cancer Drugs

Gangyi Dai
Lang He
Qin Yan
Yamao Li
Yuandong Huang
Bin Li
Guoping Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1167516

2,404 views
4 citations

Editorial

Published on 26 Jun 2023

Editorial: Novel targeted drugs for indolent lymphoid malignancies

in Pharmacology of Anti-Cancer Drugs

Tadeusz Robak
Bartosz Puła
Iwona Hus

Frontiers in Oncology

doi 10.3389/fonc.2023.1224528

1,488 views

Original Research

Published on 20 Jun 2023

Adjuvant composite cold atmospheric plasma therapy increases antitumoral effect of doxorubicin hydrochloride

in Pharmacology of Anti-Cancer Drugs

Volha Kniazeva
Dzmitry Tzerkovsky
Ömür Baysal
Alexander Kornev
Evgeny Roslyakov
Serhei Kostevitch

Frontiers in Oncology

doi 10.3389/fonc.2023.1171042

2,451 views
4 citations

Editorial

Published on 20 Jun 2023

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer, Volume II

in Pharmacology of Anti-Cancer Drugs

Weilong Zhong
Tao Sun

Frontiers in Oncology

doi 10.3389/fonc.2023.1218855

1,169 views
1 citation

Editorial

Published on 19 Jun 2023

Editorial: RNA recognition landscapes and anticancer drug targeting

in Pharmacology of Anti-Cancer Drugs

Erica Salvati
Anna Lewinska
Erik Dassi
Maciej Wnuk
Vito G. D’Agostino

Frontiers in Oncology

doi 10.3389/fonc.2023.1222883

944 views

Review

Published on 19 Jun 2023

Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma

in Pharmacology of Anti-Cancer Drugs

Yubo Xiang
Yingxin Yang
Jia Liu
Xu Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1219211

4,133 views
8 citations

Review

Published on 16 Jun 2023

Anticancer properties of sulforaphane: current insights at the molecular level

in Pharmacology of Anti-Cancer Drugs

Muhammad Asif Ali
Noohela Khan
Nabeeha Kaleem
Waqas Ahmad
Salem Hussain Alharethi
Bandar Alharbi
Hassan H. Alhassan
Maher M. Al-Enazi
Ahmad Faizal Abdull Razis
Babagana Modu

Frontiers in Oncology

doi 10.3389/fonc.2023.1168321

17,286 views
11 citations

Original Research

Published on 15 Jun 2023

Evaluating the iron chelator function of sirtinol in non-small cell lung cancer

in Pharmacology of Anti-Cancer Drugs

Michael S. Petronek
Khaliunaa Bayanbold
Koffi Amegble
Ann M. Tomanek-Chalkley
Bryan G. Allen
Douglas R. Spitz
Charvann K. Bailey

Frontiers in Oncology

doi 10.3389/fonc.2023.1185715

2,042 views
3 citations

Correction

Published on 02 Jun 2023

Corrigendum: Antiproliferative effects of the natural oxadiazine Nocuolin A are associated with impairment of mitochondrial oxidative phosphorylation

in Pharmacology of Anti-Cancer Drugs

Maria Lígia Sousa
Marco Preto
Vítor Vasconcelos
Stig Linder
Ralph Urbatzka

Frontiers in Oncology

doi 10.3389/fonc.2023.1228436

764 views

Navigation group

Articles

Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures

A literature review on the impact of disasters on healthcare systems, the role of nursing in disaster management, and strategies for cancer care delivery in disaster-affected populations

PIWIL1 interacting RNA piR-017724 inhibits proliferation, invasion, and migration, and inhibits the development of HCC by silencing PLIN3

Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens

Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects

Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies

Intravenous immunoglobulin is safe and effective in controlling pre-existing paraneoplastic neuromuscular diseases in cancer patients treated with immune checkpoint inhibitors: two case reports and literature review

Case Report: Advanced pulmonary sarcomatoid carcinoma with adrenal gland metastasis after sintilimab combined with anlotinib treatment

Editorial: Novel targeted drugs for indolent lymphoid malignancies

Adjuvant composite cold atmospheric plasma therapy increases antitumoral effect of doxorubicin hydrochloride

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer, Volume II

Editorial: RNA recognition landscapes and anticancer drug targeting

Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma

Anticancer properties of sulforaphane: current insights at the molecular level

Evaluating the iron chelator function of sirtinol in non-small cell lung cancer

Corrigendum: Antiproliferative effects of the natural oxadiazine Nocuolin A are associated with impairment of mitochondrial oxidative phosphorylation